What should be done immediately if a patient crashes during anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Patient Crashing During Anesthesia

When a patient crashes during anesthesia, immediately follow the ABC approach (Airway, Breathing, Circulation) while simultaneously calling for help, administering 100% oxygen, and preparing to give intravenous epinephrine 50 mcg (0.5 mL of 1:10,000 solution) if anaphylaxis is suspected, as this represents the most common life-threatening cause of intraoperative cardiovascular collapse. 1, 2

Immediate Recognition and Initial Actions

First 30 Seconds: Simultaneous Assessment and Intervention

  • Call for help immediately and note the time - team-working enables multiple tasks to be accomplished simultaneously 1, 2
  • Assess and secure the airway - exclude mechanical causes such as misplaced tracheal tube, circuit disconnection, or equipment failure before attributing collapse to other causes 1, 2
  • Administer 100% oxygen - intubate the trachea if necessary and ventilate the lungs with oxygen 1, 2
  • Check circulation - assess for pulse, blood pressure, and signs of cardiovascular collapse 3

Critical Differential: Anaphylaxis vs. Other Causes

Anaphylaxis is the leading consideration when a patient crashes intraoperatively, as cardiovascular collapse occurs in 50.8% of anaphylaxis cases during anesthesia 2. Key recognition points:

  • Hypotension may be the sole presenting feature in approximately 10% of patients - do not wait for cutaneous signs 2
  • Cutaneous signs are absent in 28% of cases - flushing and urticaria occur in only 72% of anaphylaxis cases 2
  • Bradycardia occurs in 10% of cases, not just tachycardia 2
  • Bronchospasm is present in 39.8% of allergic anaphylaxis cases 2

Pharmacological Management for Suspected Anaphylaxis

First-Line: Intravenous Epinephrine

Administer IV epinephrine 50 mcg (0.5 mL of 1:10,000 solution) immediately for adults with suspected anaphylaxis 1, 2, 4. This is the definitive treatment with alpha-agonist (vasoconstriction), beta-agonist (inotropy, bronchodilation), and mediator release inhibition properties 2.

  • Repeat doses every few minutes as needed for severe hypotension or bronchospasm 1, 2
  • Start continuous IV infusion if multiple boluses required - prepare 1 mg (1 mL of 1:1000) in 250 mL D5W = 4 mcg/mL, infuse at 1-4 mcg/min initially, titrate up to 10 mcg/min 2
  • Alternative infusion preparation: 1 mg in 100 mL saline (1:100,000), infuse at 30-100 mL/h (5-15 mcg/min) 2

Pediatric dosing: 1 mcg/kg IV (0.1 mL/kg of 1:10,000 solution), titrated to response - prepare 1 mL of 1:10,000 per 10 kg body weight and start with one-tenth of syringe contents 1, 2

Aggressive Fluid Resuscitation

Administer normal saline 0.9% or lactated Ringer's solution at high rate through large-bore IV cannula 1, 2, 4:

  • Adults: 1-2 L at 5-10 mL/kg in first 5 minutes - up to 7 L may be required due to massive vasodilation 5, 2, 4
  • Children: up to 30 mL/kg in first hour 2
  • Rationale: Increased vascular permeability can transfer 50% of intravascular fluid to extravascular space within 10 minutes 2

Remove All Potential Causative Agents

Stop all IV colloids, antibiotics, and remove latex exposure - maintain anesthesia only with inhalational agent if necessary 1, 2

Positioning

Elevate the patient's legs if hypotension is present to improve venous return and prevent orthostatic hypotension 1, 2, 4

Cardiopulmonary Resuscitation if Indicated

Start CPR immediately if cardiac arrest occurs, following Advanced Life Support Guidelines 1. High-quality cardiopulmonary resuscitation is necessary to reduce the duration of cerebral anoxia, as cardiac arrest causes irreversible brain damage within 3-5 minutes 3.

Secondary Management (After Initial Stabilization)

Adjunctive Medications

These are administered after epinephrine and fluids, not as first-line therapy 4:

  • Chlorphenamine 10 mg IV (adult dose) - reduces histamine-mediated symptoms 1, 5
  • Hydrocortisone 200 mg IV (adult dose) - may prevent biphasic reactions 1, 5

Pediatric dosing for adjunctive medications 1:

  • Chlorphenamine: 6-12 years: 5 mg; 6 months-6 years: 2.5 mg; <6 months: 250 mcg/kg
  • Hydrocortisone: 6-12 years: 100 mg; 6 months-6 years: 50 mg; <6 months: 25 mg

Refractory Hypotension

If blood pressure does not recover despite epinephrine infusion, consider alternative IV vasopressor such as metaraminol 1, or dopamine 400 mg in 500 mL at 2-20 mcg/kg/min 5

Persistent Bronchospasm

Treat with IV salbutamol infusion - alternatively use metered-dose inhaler if appropriate breathing-system connector available 1. Consider IV aminophylline or magnesium sulphate 1.

Bradycardia Management

Administer atropine 600 mcg IV if bradycardia develops 5

Diagnostic Confirmation: Mast Cell Tryptase

Obtain serial mast cell tryptase levels (5-10 mL clotted blood) at specific time points 1, 2, 4:

  1. First sample: As soon as feasible after resuscitation starts - do not delay resuscitation to take the sample 1, 2, 4
  2. Second sample: 1-2 hours after symptom onset 1, 2, 4
  3. Third sample: At 24 hours or in convalescence - establishes baseline, as some individuals have elevated baseline levels 1, 2

Label all samples with time and date 1

Post-Resuscitation Care and Monitoring

Immediate Transfer

Arrange transfer to Critical Care area for continued monitoring 1, 2. All patients with anaphylaxis or serious reactions should be transferred to a hospital with emergency department capabilities, even if symptoms improve 5.

Observation Requirements

  • Monitor vital signs continuously until complete resolution of symptoms 5
  • 24-hour observation is recommended after severe reactions, ideally in a hospital setting 5
  • Monitor for biphasic anaphylaxis, which occurs in 1-7% of patients, with risk factors including severe initial presentation and requiring >1 dose of epinephrine 4

Documentation

Record the following 5, 2:

  • Exact timing of reaction onset
  • All anesthetic agents administered
  • Vital signs throughout event
  • All treatments given and patient response
  • Details of any difficulties during intubation

Critical Pitfalls to Avoid

  • Never delay epinephrine administration while giving antihistamines or corticosteroids - these are not first-line therapy and do not prevent biphasic reactions 4
  • Do not exclude anaphylaxis based on absence of cutaneous signs - 28% of cases lack skin manifestations 2
  • Do not assume tachycardia will be present - bradycardia occurs in 10% of cases 2
  • Avoid multiple repeated intubation attempts if intubation is difficult - progressive laryngeal edema and hemorrhage will develop and the ability to ventilate via mask may be lost 6
  • Exclude equipment failure (misplaced tracheal tube, circuit disconnection) before attributing symptoms solely to anaphylaxis 1, 2
  • Use IV route when IV access is available in the anesthesia setting - IV allows for precise titration rather than IM administration 2

Special Considerations

  • Neuraxial blockade exaggerates hypotension in anaphylaxis 2
  • Tourniquet deflation may trigger anaphylaxis if allergen sequestered in limb 2
  • Patients with pre-existing asthma may have more prominent bronchospasm 2
  • Symptoms typically develop within minutes but may be delayed up to one hour with latex, antibiotics, IV colloids, or Cidex OPA 2

Post-Event Management

Permanently document the causative agent as a severe allergy in all medical records 5. Refer patient for allergy testing to identify specific causative agent for future avoidance 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management During Anaesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Emergency Resuscitation Techniques:Airway, Breathing, and Circulation].

No shinkei geka. Neurological surgery, 2023

Guideline

Anaphylaxis to Intravenous Agents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anaphylaxis Management in Outpatient Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.